New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

Nature Medicine
Gerald KleymannHelga Rübsamen-Waigmann

Abstract

The vast majority of the world population is infected with at least one member of the human herpesvirus family. Herpes simplex virus (HSV) infections are the cause of cold sores and genital herpes as well as life-threatening or sight-impairing disease mainly in immunocompromized patients, pregnant women and newborns. Since the milestone development in the late 1970s of acyclovir (Zovirax), a nucleosidic inhibitor of the herpes DNA polymerase, no new non-nucleosidic anti-herpes drugs have been introduced. Here we report new inhibitors of the HSV helicase-primase with potent in vitro anti-herpes activity, a novel mechanism of action, a low resistance rate and superior efficacy against HSV in animal models. BAY 57-1293 (N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide), a well-tolerated member of this class of compounds, significantly reduces time to healing, prevents rebound of disease after cessation of treatment and, most importantly, reduces frequency and severity of recurrent disease. Thus, this class of drugs has significant potential for the treatment of HSV disease in humans, including those resistant to current medications.

References

May 1, 1979·Antimicrobial Agents and Chemotherapy·C S CrumpackerM J Levin
Jan 1, 1997·Annual Review of Biochemistry·P E Boehmer, I R Lehman
Dec 11, 1999·Mayo Clinic Proceedings·M R Keating
Dec 14, 1999·Molecular Microbiology·M C Hall, S W Matson

❮ Previous
Next ❯

Citations

Sep 1, 2005·Journal of Biomedical Science·Yuh-Chi KuoWei-Jern Tsai
Jan 15, 2003·Current Infectious Disease Reports·Eugene Au, Stephen L. Sacks
Sep 28, 2013·Biochemical Pharmacology·Erik De Clercq
Mar 10, 2005·Bioorganic & Medicinal Chemistry·Brian A JohnsKelly R Moniri
May 25, 2005·Bioorganic & Medicinal Chemistry·João P C ToméMaria L Valdeira
Sep 27, 2002·Antiviral Research·Andrew J DavisonNigel D Stow
Aug 5, 2003·Antiviral Research·Robert J Visalli, Marja van Zeijl
Oct 22, 2002·Molecular and Biochemical Parasitology·Renu TutejaVirander Singh Chauhan
Mar 6, 2004·Seminars in Neonatology : SN·Patricia McClean, Suzanne M Davison
Sep 27, 2005·Nature Reviews. Drug Discovery·Ann D KwongKuan-Teh Jeang
Sep 17, 2004·Nature Reviews. Microbiology·Erik De Clercq
Mar 3, 2011·The Journal of Biological Chemistry·Isabella MuylaertPer Elias
Jul 5, 2008·Nucleosides, Nucleotides & Nucleic Acids·Min Huang, Beverly S Mitchell
Dec 24, 2009·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Erin ReichertJoseph Larsen
Jan 19, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Herbert E KaufmanGerald Kleymann
Aug 29, 2006·Nucleic Acids Research·Kuan-Teh Jeang, Venkat Yedavalli
Jul 13, 2011·Antimicrobial Agents and Chemotherapy·Anke Burger-KentischerSteffen Rupp
May 23, 2002·Antimicrobial Agents and Chemotherapy·Ulrich A K BetzHelga Rübsamen-Waigmann
Sep 16, 2003·Drug News & Perspectives·David N Frick
Nov 26, 2005·Uirusu·Yoshito Eizuru
Oct 8, 2009·Evidence-based Complementary and Alternative Medicine : ECAM·Hua-Yew ChengChun-Ching Lin
Jan 17, 2014·The New England Journal of Medicine·Anna WaldAlexander Birkmann
Apr 19, 2013·British Medical Bulletin·Hugh J Field, R Anthony Vere Hodge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.